Phone: +44 (0)1462 439877 Email: email@example.com
To ensure a smooth transition from the pre-authorisation to the post-authorisation phase of the life-cycle of a ...
31 Jul, 2019
New PV practice guidance on Pregnancy Prevention Programmes by EMA
28 Apr, 2022
Updated guidance on QPPV and PSMF requirements from 01 Jan 2021
10 Sep, 2020
UK Government publishes updated pharmacovigilance guidance for UK medicines